Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter,randomized, double-blind studies期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter,randomized, double-blind studies

Authors:	Boni E. Elewski Phoebe Rich Richard Pollak David M. Pariser Shinichi Watanabe Hisato Senda Chikara Ieda Kathleen Smith Radhakrishnan Pillai Tage Ramakrishna Jason T. Olin

Affiliation:	1. Department of Dermatology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama;2. Northwest Cutaneous Research Specialists, Portland, Oregon;3. San Antonio Podiatry Associates, San Antonio, Texas;4. Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia;5. Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan;6. Kaken Pharmaceutical Co Ltd, Kyoto, Japan;^g Kaken Pharmaceutical Co Ltd, Tokyo, Japan;^h Dow Pharmaceutical Sciences Inc, (a division of Valeant Pharmaceuticals North America LLC) Petaluma, California;ⁱ Valeant Pharmaceuticals North America LLC, Bridgewater, New Jersey

Abstract:

Keywords:	efficacy efinaconazole onychomycosis randomized controlled trials safety topical triazole antifungal
本文献已被 ScienceDirect 等数据库收录！